MImAbs is an innovative start-up specialized in immunotherapy. Our goal is to develop monoclonal antibodies in cancer and inflammatory diseases for third parties (academics, pharmacuetical companies, biotechnologies, etc.)
Company Details
- Employees
- 35
- Founded
- -
- Address
- Avenue De Luminy, Marseille,13009,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- mimabs.org
- Keywords
- Anticorps monoclonaux, Immuno-pharmacologie, Génération et bioproduction d'anticorps, Génération d'immunoconjugués.
- HQ
- MARSEILLE
Mimabs Sas Questions
Mimabs Sas's website is mimabs.org
Mimabs Sas's LinkedIn profile is https://fr.linkedin.com/company/mimabs
Mimabs Sas has
35 employees.
View email and phone details for 35
employees at Mimabs Sas.
Mimabs Sas's industry is
Biotechnology Research
Mimabs Sas's top competitors are
Treefrog Therapeutics,
Oz Biosciences,
Jc Discovery,
Ose Immunotherapeutics,
Eurobiomed,
Provepharm,
Phaxiam Therapeutics,
Imcheck Therapeutics,
Innate Pharma,
Edelris.
Mimabs Sas's categories are Biotechnology Research
Mimabs Sas's founding year is 2012
